Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Addgene

pLKO.1-TRC.mKO2 Citations (1)

Originally described in: Guanylate-binding protein-1 is a potential new therapeutic target for triple-negative breast cancer.
Quintero M, Adamoski D, Reis LMD, Ascencao CFR, Oliveira KRS, Goncalves KA, Dias MM, Carazzolle MF, Dias SMG BMC Cancer. 2017 Nov 7;17(1):727. doi: 10.1186/s12885-017-3726-2. PubMed Journal

Articles Citing pLKO.1-TRC.mKO2

Articles
Guanylate-binding protein-1 is a potential new therapeutic target for triple-negative breast cancer. Quintero M, Adamoski D, Reis LMD, Ascencao CFR, Oliveira KRS, Goncalves KA, Dias MM, Carazzolle MF, Dias SMG. BMC Cancer. 2017 Nov 7;17(1):727. doi: 10.1186/s12885-017-3726-2. PubMed

Associated Plasmids

If you have published an article using this material, please email us at [email protected] to have your article added to this page.